Liquid Biopsies in Lung Cancer: Know the Basics

Video

Liquid biopsies are becoming essential in the lung cancer arena.

Liquid biopsies are becoming an integral part of the diagnosis and treatment planning for patients with lung cancer, explained Adijan Kuckovic, a graduate student researcher at the University of Illinois College of Medicine at Rockford.

Patients undergoing a liquid biopsy will first have their blood and platelets drawn. Then, the DNA will be isolated, and expression panels will be run to see if the person has certain cancer markers. The process is currently one of the most highly specific technologies available in the lung cancer space.

Recent Videos
5 experts in this video
5 experts in this video
Image of Jessie Desir, PhD, RN, AMB-BC, OCN, in a video call with a blue and gold Oncology Nursing News border surrounding the frame.
5 experts in this video
5 experts in this video
Related Content
Digital rendering of lungs on a dark blue background

First-Line Amivantamab With Lazertinib Boosts OS in EGFR-Mutated NSCLC

Kristi Rosa
April 3rd 2025
Article

The combination of amivantamab and Lazertinib improved long-term survival over osimertinib in patients with EGFR-mutated non-small cell lung cancer.

The Vitals

Nicole Gay Shares How She Counsels Patients on Lung Cancer Screenings

Lindsay Fischer
November 15th 2023
Podcast

Nicole Gay, APRN-C, shares how nurse navigators can talk to their patients about lung cancer screening.

Line illustration of lungs on a cornflower blue background

Osimertinib Sustains OS Improvement in EGFR-Mutant NSCLC

Roman Fabbricatore
March 31st 2025
Article

Osimertinib monotherapy and combination treatment had safety profiles consistent with previous data on use of the drug in EGFR-mutated NSCLC.

Oncology Nursing News

A Look Back at 2022 FDA Approvals in Oncology

Oncology Nursing News
January 2nd 2023
Podcast

In this episode of The Vitals, we recount the oncology drugs that received FDA approvals in 2022.

Image of a calendar with a thumb tack stuck on a day reading "20," and a stethoscope lying on the calendar, with an image of a clock overlaying

Opinion: Oncology Nurses Can Ease the Burden of Time Toxicity in Cancer Care

Amanda Brink, DNP, APRN, FNP-BC, AOCNP
February 26th 2025
Article

Similar to financial toxicity, time toxicity can have a profound impact on a patient’s quality of life.

Illustration of lungs with a magnifying glass inspecting them

Serial CTRS Receives FDA Breakthrough Device Designation for NSCLC Prognosis

Chris Ryan
February 11th 2025
Article

Serial CTRS, an AI-powered tool, has been granted FDA breakthrough device designation for classifying patients with NSCLC.